Dr. Douglas Boven, M.D

NPI: 1255696092
Total Payments
$403.68
2017 Payments
$403.68
Companies
13
Transactions
28
Medicare Patients
5,165
Medicare Billing
$682,336

Payment Breakdown by Category

Food & Beverage$403.68 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $403.68 28 100.0%

Top Paying Companies

Company Total Records Latest Year
Valeant Pharmaceuticals North America LLC $90.64 5 $0 (2017)
PFIZER INC. $58.87 4 $0 (2017)
Purdue Pharma L.P. $53.19 4 $0 (2017)
Allergan Inc. $30.43 2 $0 (2017)
Pernix Therapeutics Holdings, Inc. $25.80 2 $0 (2017)
Daiichi Sankyo Inc. $25.42 2 $0 (2017)
Kaleo, Inc. $24.26 2 $0 (2017)
MERZ NORTH AMERICA, INC. $24.09 2 $0 (2017)
Avanir Pharmaceuticals, Inc. $17.38 1 $0 (2017)
Medtronic USA, Inc. $16.85 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2017 $403.68 28 Valeant Pharmaceuticals North America LLC ($90.64)

All Payment Transactions

28 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
08/29/2017 PFIZER INC. LYRICA (Drug) Food and Beverage In-kind items and services $15.39 General
Category: NEUROSCIENCE;PAIN
08/17/2017 Depomed, Inc. Nucynta (Drug), Gralise Food and Beverage In-kind items and services $11.64 General
Category: Pain
07/26/2017 Allergan Inc. BOTOX NEURO REHAB (Drug) Food and Beverage In-kind items and services $12.83 General
Category: NEUROSCIENCE
07/21/2017 Purdue Pharma L.P. HYSINGLA ER (Drug) Food and Beverage Cash or cash equivalent $10.78 General
Category: PAIN MANAGEMENT
05/18/2017 MERZ NORTH AMERICA, INC. Xeomin (Biological) Food and Beverage Cash or cash equivalent $11.08 General
Category: Musculoskeletal
05/17/2017 PFIZER INC. LYRICA (Drug) Food and Beverage In-kind items and services $15.00 General
Category: NEUROSCIENCE;PAIN
05/10/2017 Valeant Pharmaceuticals North America LLC XIFAXAN (Drug), RELISTOR ORAL Food and Beverage In-kind items and services $18.39 General
Category: GASTROENTEROLOGY
05/03/2017 Purdue Pharma L.P. BUTRANS (Drug), OXYCONTIN, HYSINGLA ER Food and Beverage Cash or cash equivalent $10.97 General
Category: PAIN MANAGEMENT
04/26/2017 PFIZER INC. LYRICA (Drug), FLECTOR PATCH, EMBEDA Food and Beverage In-kind items and services $16.26 General
Category: NEUROSCIENCE;PAIN
04/12/2017 Valeant Pharmaceuticals North America LLC RELISTOR ORAL (Drug), XIFAXAN, RELISTOR Food and Beverage In-kind items and services $16.70 General
Category: GASTROENTEROLOGY
04/07/2017 Medtronic USA, Inc. ADAPTIVESTIM (Device) Food and Beverage In-kind items and services $16.85 General
Category: Spinal Cord Neurostimulation
03/23/2017 Pernix Therapeutics Holdings, Inc. ZOHYDRO ER (Drug) Food and Beverage In-kind items and services $11.92 General
Category: PAIN
03/15/2017 Valeant Pharmaceuticals North America LLC RELISTOR ORAL (Drug), XIFAXAN, RELISTOR Food and Beverage In-kind items and services $21.60 General
Category: GASTROENTEROLOGY
03/09/2017 MERZ NORTH AMERICA, INC. Xeomin (Biological) Food and Beverage Cash or cash equivalent $13.01 General
Category: Musculoskeletal
03/02/2017 Egalet US Inc OXAYDO (Drug) Food and Beverage In-kind items and services $11.00 General
Category: Pain Medicine
02/28/2017 Allergan Inc. BOTOX NEURO REHAB (Drug) Food and Beverage In-kind items and services $17.60 General
Category: NEUROSCIENCE
02/24/2017 PFIZER INC. FLECTOR PATCH (Drug), EMBEDA, LYRICA Food and Beverage In-kind items and services $12.22 General
Category: INFLAMMATION;PAIN
02/17/2017 Kaleo, Inc. Evzio (Drug) Food and Beverage In-kind items and services $11.21 General
Category: Opioid Antagonist
02/07/2017 Valeant Pharmaceuticals North America LLC RELISTOR ORAL (Drug), XIFAXAN, RELISTOR Food and Beverage In-kind items and services $16.52 General
Category: GASTROENTEROLOGY
02/06/2017 Daiichi Sankyo Inc. Movantik (Drug) Food and Beverage In-kind items and services $12.35 General
Category: Opioid Induced Constipation
01/24/2017 Pernix Therapeutics Holdings, Inc. ZOHYDRO ER (Drug) Food and Beverage In-kind items and services $13.88 General
Category: PAIN
01/17/2017 Valeant Pharmaceuticals North America LLC RELISTOR (Drug), RELISTOR ORAL Food and Beverage In-kind items and services $17.43 General
Category: GASTROENTEROLOGY
01/17/2017 Daiichi Sankyo Inc. Movantik (Drug) Food and Beverage In-kind items and services $13.07 General
Category: Opioid Induced Constipation
01/16/2017 Kaleo, Inc. Evzio (Drug) Food and Beverage In-kind items and services $13.05 General
Category: Opioid Antagonist
01/13/2017 Avanir Pharmaceuticals, Inc. ONZETRA Xsail (Drug) Food and Beverage In-kind items and services $17.38 General
Category: Migraine

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 21 1,383 3,680 $387,116 $199,073
2022 21 1,373 3,405 $332,717 $168,221
2021 18 1,275 3,000 $309,086 $158,889
2020 17 1,134 2,349 $297,337 $156,153
Total Patients
5,165
Total Services
12,434
Medicare Billing
$682,336
Procedure Codes
78

All Medicare Procedures & Services

78 procedure records from CMS Medicare Utilization — Page 1 of 4

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99310 Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes Facility 2023 106 297 $71,025 $36,653 51.6%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 210 465 $44,395 $29,743 67.0%
99306 Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes Facility 2023 125 148 $42,940 $21,536 50.2%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 99 202 $27,340 $19,497 71.3%
99308 Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes Facility 2023 107 298 $36,070 $17,867 49.5%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 118 118 $21,335 $12,506 58.6%
64483 Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level Office 2023 36 59 $28,240 $11,615 41.1%
20611 Aspiration and/or injection of fluid large joint using ultrasound guidance Office 2023 68 122 $30,528 $11,332 37.1%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 66 67 $18,090 $9,422 52.1%
27096 Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance Office 2023 41 50 $24,050 $7,820 32.5%
95886 Needle measurement of electrical activity in arm or leg muscles, complete study Office 2023 39 55 $9,325 $4,268 45.8%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 28 28 $6,175 $3,747 60.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 35 38 $6,346 $3,716 58.6%
99238 Hospital discharge day management, 30 minutes or less Facility 2023 56 57 $7,581 $3,680 48.5%
95908 Nerve conduction, 3-4 studies Office 2023 22 22 $4,840 $1,865 38.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 23 24 $2,832 $1,700 60.0%
99309 Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes Facility 2023 14 15 $2,250 $1,284 57.1%
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg Office 2023 99 832 $2,879 $698.79 24.3%
J1100 Injection, dexamethasone sodium phosphate, 1 mg Office 2023 40 709 $709.00 $69.47 9.8%
A9576 Injection, gadoteridol, (prohance multipack), per ml Office 2023 29 46 $138.00 $51.63 37.4%
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Office 2023 22 28 $28.00 $2.84 10.1%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 334 567 $53,865 $32,688 60.7%
99310 Follow-up nursing facility visit per day, typically 35 minutes Facility 2022 70 187 $42,075 $20,144 47.9%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 140 142 $25,560 $15,683 61.4%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 110 172 $23,220 $14,262 61.4%

About Dr. Douglas Boven, M.D

Dr. Douglas Boven, M.D is a Physical Medicine & Rehabilitation healthcare provider based in Royal Oak, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/09/2012. The National Provider Identifier (NPI) number assigned to this provider is 1255696092.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Douglas Boven, M.D has received a total of $403.68 in payments from pharmaceutical and medical device companies, with $403.68 received in 2017. These payments were reported across 28 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($403.68).

As a Medicare-enrolled provider, Boven has provided services to 5,165 Medicare beneficiaries, totaling 12,434 services with total Medicare billing of $682,336. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.

Practice Information

  • Specialty Physical Medicine & Rehabilitation
  • Location Royal Oak, MI
  • Active Since 07/09/2012
  • Last Updated 07/28/2022
  • Taxonomy Code 208100000X
  • Entity Type Individual
  • NPI Number 1255696092

Products in Payments

  • RELISTOR ORAL (Drug) $54.82
  • LYRICA (Drug) $46.65
  • HYSINGLA ER (Drug) $42.22
  • BOTOX NEURO REHAB (Drug) $30.43
  • ZOHYDRO ER (Drug) $25.80
  • Movantik (Drug) $25.42
  • Evzio (Drug) $24.26
  • Xeomin (Biological) $24.09
  • XIFAXAN (Drug) $18.39
  • RELISTOR (Drug) $17.43
  • ONZETRA Xsail (Drug) $17.38
  • ADAPTIVESTIM (Device) $16.85
  • Fentanyl (Drug) $14.11
  • FLECTOR PATCH (Drug) $12.22
  • Nucynta (Drug) $11.64
  • OXAYDO (Drug) $11.00
  • BUTRANS (Drug) $10.97

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Physical Medicine & Rehabilitation Doctors in Royal Oak